These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28295291)

  • 1. Study of the extent of information desired by women undergoing non-invasive prenatal testing following positive prenatal Down-syndrome screening test results.
    Lo TK; Chan KY; Kan AS; So PL; Kong CW; Mak SL; Lee CN
    Int J Gynaecol Obstet; 2017 Jun; 137(3):338-339. PubMed ID: 28295291
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnant women support extra screening test for Down's syndrome.
    Kmietowicz Z
    BMJ; 2014 Sep; 349():g5830. PubMed ID: 25248978
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA sequencing versus standard prenatal aneuploidy screening.
    Vrachnis N; Vlachadis N; Creatsas G
    N Engl J Med; 2014 Aug; 371(6):578. PubMed ID: 25099589
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA sequencing versus standard prenatal aneuploidy screening.
    Liao C; Zhengfeng X; Zhang K
    N Engl J Med; 2014 Aug; 371(6):577-8. PubMed ID: 25099588
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Rava RP; Sehnert AJ
    N Engl J Med; 2014 Aug; 371(6):578. PubMed ID: 25099587
    [No Abstract]   [Full Text] [Related]  

  • 7. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening.
    Rafi I; Hill M; Hayward J; Chitty LS
    Br J Gen Pract; 2017 Jul; 67(660):298-299. PubMed ID: 28663415
    [No Abstract]   [Full Text] [Related]  

  • 9. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive prenatal testing is a breakthrough in prenatal screening].
    Hornstrup LS; Ambye L; Sørensen S; Jørgensen FS
    Ugeskr Laeger; 2015 Jul; 177(28):. PubMed ID: 26239855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
    Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
    Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical genetics: DNA sequencing trumps standard screening tools.
    Koch L
    Nat Rev Genet; 2014 May; 15(5):288. PubMed ID: 24637914
    [No Abstract]   [Full Text] [Related]  

  • 13. Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women?
    Bianchi DW; Oepkes D; Ghidini A
    Prenat Diagn; 2014 Jan; 34(1):6-11. PubMed ID: 24002925
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening.
    Lofsky S
    CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
    [No Abstract]   [Full Text] [Related]  

  • 15. Options for Down syndrome screening: what will women choose?
    Grant SS
    J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quadruple test for Down syndrome screening in pregnant women of advanced maternal age.
    Kwon JY; Park IY; Kwon SM; Kim CJ; Shin JC
    Arch Gynecol Obstet; 2012 Mar; 285(3):629-33. PubMed ID: 21837420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does offering prenatal screening influence pregnant women's attitudes regarding prenatal testing?
    Kleinveld JH; van den Berg M; van Eijk JT; van Vugt JM; van der Wal G; Timmermans DR
    Community Genet; 2008; 11(6):368-74. PubMed ID: 18690005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid aneuploidy test for positive Down screening: who is willing to pay for it?
    Lo TK; Leung WC; Lau WL; Lam H; Lai FK; Ng LS; Wong WC; Chan A; Chin RK
    J Matern Fetal Neonatal Med; 2010 Jul; 23(7):747-9. PubMed ID: 19701862
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
    Tercanli S; Vial Y; Merz E
    Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.